We found no significant gains over the vanilla ENT baseline with both strategies.
down-sampling resulted in gains of only 0.002 and 0.001 F-score and up-sampling resulted in a drop of 0.011 and 0.013 F-score on clinicaldev and newswire-dev, respectively.